A Novel Phase-2a Clinical Trial for a Next-Generation Oncolytic Immunotherapy Targeting Platinum-Resistant Ovarian Cancer

{
  "url": [
    "https://ec.europa.eu/info/funding-tenders/opportunities/horizon/hop-on/101289129"
  ],
  "type": [
    "11"
  ],
  "title": [
    "A Novel Phase-2a Clinical Trial for a Next-Generation Oncolytic Immunotherapy Targeting Platinum-Resistant Ovarian Cancer"
  ],
  "caName": [
    "OCTOPOD-Ph2a"
  ],
  "esST_URL": [
    "https://ec.europa.eu/info/funding-tenders/opportunities/horizon/hop-on/101289129"
  ],
  "keywords": [
    "OCTOPOD-Ph2a"
  ],
  "language": [
    "en"
  ],
  "REFERENCE": [
    "HOP_ON_PROJECT101289129"
  ],
  "startDate": [
    "2026-06-01T00:00:00.000+0000"
  ],
  "DATASOURCE": [
    "SEDIA"
  ],
  "identifier": [
    "101289129"
  ],
  "closingDate": [
    "2029-05-31T00:00:00Z"
  ],
  "es_SortDate": [
    "2026-06-01T00:00:00.000+0000"
  ],
  "esST_FileName": [
    "file.txt"
  ],
  "esST_checksum": [
    "7E22DA7FF913CF27E4193DCA96982B7B8D8205B0A7E98467065A5F525F6A86C2"
  ],
  "callIdentifier": [
    "HORIZON-HLTH-2025-01-TOOL-05"
  ],
  "esDA_QueueDate": [
    "2026-05-22T16:25:11.993+0200"
  ],
  "es_ContentType": [
    "text/plain"
  ],
  "esDA_IngestDate": [
    "2026-05-22T16:25:12.005+0200"
  ],
  "geographicalZones": [
    "United Kingdom"
  ],
  "programmeDivision": [
    "Health"
  ],
  "esDA_FirstIngestDate": [
    "2026-05-22T16:25:12.005+0200"
  ],
  "beneficiaryAdministration": [
    "879746933"
  ]
}